HESI/US FDA Seminar: Risk Assessment in the 21st Century (RISK21)

College Park, Maryland, USA
February 18, 2014

At the invitation of the US Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN), the HESI Risk Assessment in the 21st Century (RISK21) Technical Committee conducted a half-day seminar on the RISK21 approach on 18 February 2014 at FDA in College Park, Maryland. Approximately 50 FDA scientists from various centers participated in person and over 50 participants connected remotely via webinar or telephone. The seminar, organized by Dr. Sabine Francke-Carroll (US FDA/CFSAN), Dr. Suzanne Fitzpatrick (US FDA/CFSAN), and Dr. Michelle Embry (HESI), included introductory risk assessment perspectives from FDA and presentations by RISK21 leaders on the RISK21 problem formulation-based, exposure-driven, tiered data acquisition approach. A panel discussion with RISK21 and FDA representatives focused on the potential utility and applications of the RISK21 approach within FDA.

Speaker Presentations

For more information about the seminar, contact Dr. Michelle Embry (membry@hesiglobal.org), Ms. Nancy Doerrer (ndoerrer@hesiglobal.org), or Dr. Jennifer Young Tanir (jtanir@hesiglobal.org).